ConductScience.org, home
A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
API referenceFor AI assistants

Trial · NCT01981122

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 20

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Baseline2.48Standard Deviation 4.7610^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Baseline1.48Standard Deviation .9210^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Pre-leuk 28.76Standard Deviation 13.4010^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Pre-leuk 25.08Standard Deviation 7.0710^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Pre-leuk 323.33Standard Deviation 16.9810^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Pre-leuk 313.96Standard Deviation 11.9010^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 617.36Standard Deviation 14.3910^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 612.72Standard Deviation 11.8310^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 1015.48Standard Deviation 9.5310^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 1010.90Standard Deviation 9.0710^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 1417.05Standard Deviation 18.7210^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 1413.05Standard Deviation 13.2810^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 2022.33Standard Deviation 20.2310^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 2017.83Standard Deviation 13.8010^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 2627.07Standard Deviation 18.2610^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 2615.39Standard Deviation 10.5810^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 4018.64Standard Deviation 15.4810^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 4013.70Standard Deviation 11.2810^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Concurrent ArmPA2024 Week 5216.67Standard Deviation 13.1310^3 cells/mL
To Evaluate Peripheral PA2024-specific T Cell Proliferation Response to Sipuleucel-T Over Time Via a T Cell Stimulation Index (SI).Sequential ArmPA2024 Week 5225.43Standard Deviation 18.7210^3 cells/mL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01981122/results

API referenceFor AI assistants